Common Contracts
11 similar Warrant Agreement contracts by Pluristem Therapeutics Inc, Galena Biopharma, Inc., Cleveland Biolabs Inc, Foundation Healthcare, Inc.
ContractWarrant Agreement • May 5th, 2020 • Delaware
EX-4.1 3 exhibit41-formofwarrantagr.htm EXHIBIT 4.1 FORM OF WARRANT AGREEMENT THIS WARRANT AGREEMENT made as of September [ ], 2013 (the “Issuance Date”), between Galena Biopharma, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a national banking association (collectively, the “Warrant Agent”). WHEREAS, the Company has sold units (the “Units”), each consisting of one share of common stock, par value $0.0001 per share (the “Common Stock”), of the Company and one warrant to purchase 0.35 of a share of Common Stock (each, a “Warrant Share” and, collectively, the “Warrant Shares”) subject to adjustment as described herein (each, a “Warrant” and, collectively, the “Warrants”), pursuant to an Underwriting Agreement between the Company and Oppenheimer & Co. Inc., as Representative of the Underwriters, dated September 13, 2013 (the “Underwriting Agreement”); and WHEREAS, both the Comm
WARRANT AGREEMENTWarrant Agreement • February 10th, 2017 • Galena Biopharma, Inc. • Pharmaceutical preparations • New York
THIS WARRANT AGREEMENT made as of February 13, 2017 (the “Issuance Date”), between Galena Biopharma, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (and together with Computershare, the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • August 6th, 2015 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS WARRANT AGREEMENT made as of March 18, 2015 (the “Issuance Date”), between Galena Biopharma, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (and together with Computershare, the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • February 9th, 2015 • Foundation Healthcare, Inc. • Services-specialty outpatient facilities, nec • New York
THIS WARRANT AGREEMENT is made as of , 2015 (the “Issuance Date”), between Foundation Healthcare, Inc., an Oklahoma corporation (the “Company”), Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (collectively, the “Warrant Agent”), and Roy T. Oliver, Valiant Investments, LLC and Oliver Company Holdings, LLC (the “Selling Stockholders”).
WARRANT AGREEMENTWarrant Agreement • September 18th, 2013 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS WARRANT AGREEMENT made as of September 18, 2013 (the “Issuance Date”), between Galena Biopharma, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (collectively, the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • November 6th, 2012 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGREEMENT made as of September 19, 2012 (“Issuance Date”), between Pluristem Therapeutics Inc., a Nevada corporation (“Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company (“Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • October 22nd, 2012 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York
THIS WARRANT AGREEMENT made as of October [_], 2012 (the “Issuance Date”), between Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • September 19th, 2012 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGREEMENT made as of September [·], 2012 (“Issuance Date”), between Pluristem Therapeutics Inc., a Nevada corporation (“Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company (“Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • September 14th, 2012 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGREEMENT made as of September [·], 2012 (“Issuance Date”), between Pluristem Therapeutics Inc., a Nevada corporation (“Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company (“Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • February 9th, 2011 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGREEMENTWarrant Agreement • January 27th, 2011 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGREEMENT made as of February 1, 2011 (“Issuance Date”), between Pluristem Therapeutics Inc., a Nevada corporation (“Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company (“Warrant Agent”).
